Global Cell Therapy CDMO Market growth is projected to reach USD $ Billion in 2025, at a $% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2025 to 2031.

Global Cell Therapy CDMO Market Growth and Outlook 2025-31

The global Cell Therapy CDMO market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Cell Therapy CDMO is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Cell Therapy CDMO players cover Charles River, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the ?Cell Therapy CDMO Industry Forecast? looks at past sales and reviews total world Cell Therapy CDMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Cell Therapy CDMO sales for 2025 through 2031. With Cell Therapy CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Therapy CDMO industry. This Insight Report provides a comprehensive analysis of the global Cell Therapy CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell Therapy CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Cell Therapy CDMO market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Therapy CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Therapy CDMO. This report presents a comprehensive overview, market shares, and growth opportunities of Cell Therapy CDMO market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Stem Cell &nbsp;&nbsp;&nbsp; Non-Stem Cell Segmentation by Application: &nbsp;&nbsp;&nbsp; Commercial &nbsp;&nbsp;&nbsp; Academic Research &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Charles River &nbsp;&nbsp;&nbsp; The Discovery Labs &nbsp;&nbsp;&nbsp; BIOCENTRIQ &nbsp;&nbsp;&nbsp; FUJIFILM Diosynth Biotechnologies &nbsp;&nbsp;&nbsp; Exothera &nbsp;&nbsp;&nbsp; WuXi AppTec &nbsp;&nbsp;&nbsp; Pharmaron &nbsp;&nbsp;&nbsp; OBiO &nbsp;&nbsp;&nbsp; Cell Therapies &nbsp;&nbsp;&nbsp; AGC Biologics &nbsp;&nbsp;&nbsp; Cytiva &nbsp;&nbsp;&nbsp; Helixmith &nbsp;&nbsp;&nbsp; ThermoGenesis &nbsp;&nbsp;&nbsp; Anemocyte &nbsp;&nbsp;&nbsp; Thermo Fisher Scientific &nbsp;&nbsp;&nbsp; CBM &nbsp;&nbsp;&nbsp; Bio Elpida &nbsp;&nbsp;&nbsp; Genezen &nbsp;&nbsp;&nbsp; CCRM &nbsp;&nbsp;&nbsp; RoslinCT &nbsp;&nbsp;&nbsp; GenScript ProBio

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Cell Therapy CDMO Market Size (2020-2031) &nbsp;2.1.2 Cell Therapy CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Cell Therapy CDMO by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Cell Therapy CDMO Segment by Type &nbsp;2.2.1 Stem Cell &nbsp;2.2.2 Non-Stem Cell &nbsp;2.3 Cell Therapy CDMO Market Size by Type &nbsp;2.3.1 Cell Therapy CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Cell Therapy CDMO Market Size Market Share by Type (2020-2025) &nbsp;2.4 Cell Therapy CDMO Segment by Application &nbsp;2.4.1 Commercial &nbsp;2.4.2 Academic Research &nbsp;2.4.3 Others &nbsp;2.5 Cell Therapy CDMO Market Size by Application &nbsp;2.5.1 Cell Therapy CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Cell Therapy CDMO Market Size Market Share by Application (2020-2025) 3 Cell Therapy CDMO Market Size by Player &nbsp;3.1 Cell Therapy CDMO Market Size Market Share by Player &nbsp;3.1.1 Global Cell Therapy CDMO Revenue by Player (2020-2025) &nbsp;3.1.2 Global Cell Therapy CDMO Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Cell Therapy CDMO Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Cell Therapy CDMO by Region &nbsp;4.1 Cell Therapy CDMO Market Size by Region (2020-2025) &nbsp;4.2 Global Cell Therapy CDMO Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Cell Therapy CDMO Market Size Growth (2020-2025) &nbsp;4.4 APAC Cell Therapy CDMO Market Size Growth (2020-2025) &nbsp;4.5 Europe Cell Therapy CDMO Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Cell Therapy CDMO Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Cell Therapy CDMO Market Size by Country (2020-2025) &nbsp;5.2 Americas Cell Therapy CDMO Market Size by Type (2020-2025) &nbsp;5.3 Americas Cell Therapy CDMO Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Cell Therapy CDMO Market Size by Region (2020-2025) &nbsp;6.2 APAC Cell Therapy CDMO Market Size by Type (2020-2025) &nbsp;6.3 APAC Cell Therapy CDMO Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Cell Therapy CDMO Market Size by Country (2020-2025) &nbsp;7.2 Europe Cell Therapy CDMO Market Size by Type (2020-2025) &nbsp;7.3 Europe Cell Therapy CDMO Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Cell Therapy CDMO by Region (2020-2025) &nbsp;8.2 Middle East & Africa Cell Therapy CDMO Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Cell Therapy CDMO Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Cell Therapy CDMO Market Forecast &nbsp;10.1 Global Cell Therapy CDMO Forecast by Region (2026-2031) &nbsp;10.1.1 Global Cell Therapy CDMO Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Cell Therapy CDMO Forecast &nbsp;10.1.3 APAC Cell Therapy CDMO Forecast &nbsp;10.1.4 Europe Cell Therapy CDMO Forecast &nbsp;10.1.5 Middle East & Africa Cell Therapy CDMO Forecast &nbsp;10.2 Americas Cell Therapy CDMO Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Cell Therapy CDMO Forecast &nbsp;10.2.2 Canada Market Cell Therapy CDMO Forecast &nbsp;10.2.3 Mexico Market Cell Therapy CDMO Forecast &nbsp;10.2.4 Brazil Market Cell Therapy CDMO Forecast &nbsp;10.3 APAC Cell Therapy CDMO Forecast by Region (2026-2031) &nbsp;10.3.1 China Cell Therapy CDMO Market Forecast &nbsp;10.3.2 Japan Market Cell Therapy CDMO Forecast &nbsp;10.3.3 Korea Market Cell Therapy CDMO Forecast &nbsp;10.3.4 Southeast Asia Market Cell Therapy CDMO Forecast &nbsp;10.3.5 India Market Cell Therapy CDMO Forecast &nbsp;10.3.6 Australia Market Cell Therapy CDMO Forecast &nbsp;10.4 Europe Cell Therapy CDMO Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Cell Therapy CDMO Forecast &nbsp;10.4.2 France Market Cell Therapy CDMO Forecast &nbsp;10.4.3 UK Market Cell Therapy CDMO Forecast &nbsp;10.4.4 Italy Market Cell Therapy CDMO Forecast &nbsp;10.4.5 Russia Market Cell Therapy CDMO Forecast &nbsp;10.5 Middle East & Africa Cell Therapy CDMO Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Cell Therapy CDMO Forecast &nbsp;10.5.2 South Africa Market Cell Therapy CDMO Forecast &nbsp;10.5.3 Israel Market Cell Therapy CDMO Forecast &nbsp;10.5.4 Turkey Market Cell Therapy CDMO Forecast &nbsp;10.6 Global Cell Therapy CDMO Forecast by Type (2026-2031) &nbsp;10.7 Global Cell Therapy CDMO Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Cell Therapy CDMO Forecast 11 Key Players Analysis &nbsp;11.1 Charles River &nbsp;11.1.1 Charles River Company Information &nbsp;11.1.2 Charles River Cell Therapy CDMO Product Offered &nbsp;11.1.3 Charles River Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Charles River Main Business Overview &nbsp;11.1.5 Charles River Latest Developments &nbsp;11.2 The Discovery Labs &nbsp;11.2.1 The Discovery Labs Company Information &nbsp;11.2.2 The Discovery Labs Cell Therapy CDMO Product Offered &nbsp;11.2.3 The Discovery Labs Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 The Discovery Labs Main Business Overview &nbsp;11.2.5 The Discovery Labs Latest Developments &nbsp;11.3 BIOCENTRIQ &nbsp;11.3.1 BIOCENTRIQ Company Information &nbsp;11.3.2 BIOCENTRIQ Cell Therapy CDMO Product Offered &nbsp;11.3.3 BIOCENTRIQ Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 BIOCENTRIQ Main Business Overview &nbsp;11.3.5 BIOCENTRIQ Latest Developments &nbsp;11.4 FUJIFILM Diosynth Biotechnologies &nbsp;11.4.1 FUJIFILM Diosynth Biotechnologies Company Information &nbsp;11.4.2 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Product Offered &nbsp;11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 FUJIFILM Diosynth Biotechnologies Main Business Overview &nbsp;11.4.5 FUJIFILM Diosynth Biotechnologies Latest Developments &nbsp;11.5 Exothera &nbsp;11.5.1 Exothera Company Information &nbsp;11.5.2 Exothera Cell Therapy CDMO Product Offered &nbsp;11.5.3 Exothera Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Exothera Main Business Overview &nbsp;11.5.5 Exothera Latest Developments &nbsp;11.6 WuXi AppTec &nbsp;11.6.1 WuXi AppTec Company Information &nbsp;11.6.2 WuXi AppTec Cell Therapy CDMO Product Offered &nbsp;11.6.3 WuXi AppTec Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 WuXi AppTec Main Business Overview &nbsp;11.6.5 WuXi AppTec Latest Developments &nbsp;11.7 Pharmaron &nbsp;11.7.1 Pharmaron Company Information &nbsp;11.7.2 Pharmaron Cell Therapy CDMO Product Offered &nbsp;11.7.3 Pharmaron Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Pharmaron Main Business Overview &nbsp;11.7.5 Pharmaron Latest Developments &nbsp;11.8 OBiO &nbsp;11.8.1 OBiO Company Information &nbsp;11.8.2 OBiO Cell Therapy CDMO Product Offered &nbsp;11.8.3 OBiO Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 OBiO Main Business Overview &nbsp;11.8.5 OBiO Latest Developments &nbsp;11.9 Cell Therapies &nbsp;11.9.1 Cell Therapies Company Information &nbsp;11.9.2 Cell Therapies Cell Therapy CDMO Product Offered &nbsp;11.9.3 Cell Therapies Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Cell Therapies Main Business Overview &nbsp;11.9.5 Cell Therapies Latest Developments &nbsp;11.10 AGC Biologics &nbsp;11.10.1 AGC Biologics Company Information &nbsp;11.10.2 AGC Biologics Cell Therapy CDMO Product Offered &nbsp;11.10.3 AGC Biologics Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 AGC Biologics Main Business Overview &nbsp;11.10.5 AGC Biologics Latest Developments &nbsp;11.11 Cytiva &nbsp;11.11.1 Cytiva Company Information &nbsp;11.11.2 Cytiva Cell Therapy CDMO Product Offered &nbsp;11.11.3 Cytiva Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Cytiva Main Business Overview &nbsp;11.11.5 Cytiva Latest Developments &nbsp;11.12 Helixmith &nbsp;11.12.1 Helixmith Company Information &nbsp;11.12.2 Helixmith Cell Therapy CDMO Product Offered &nbsp;11.12.3 Helixmith Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Helixmith Main Business Overview &nbsp;11.12.5 Helixmith Latest Developments &nbsp;11.13 ThermoGenesis &nbsp;11.13.1 ThermoGenesis Company Information &nbsp;11.13.2 ThermoGenesis Cell Therapy CDMO Product Offered &nbsp;11.13.3 ThermoGenesis Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 ThermoGenesis Main Business Overview &nbsp;11.13.5 ThermoGenesis Latest Developments &nbsp;11.14 Anemocyte &nbsp;11.14.1 Anemocyte Company Information &nbsp;11.14.2 Anemocyte Cell Therapy CDMO Product Offered &nbsp;11.14.3 Anemocyte Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Anemocyte Main Business Overview &nbsp;11.14.5 Anemocyte Latest Developments &nbsp;11.15 Thermo Fisher Scientific &nbsp;11.15.1 Thermo Fisher Scientific Company Information &nbsp;11.15.2 Thermo Fisher Scientific Cell Therapy CDMO Product Offered &nbsp;11.15.3 Thermo Fisher Scientific Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 Thermo Fisher Scientific Main Business Overview &nbsp;11.15.5 Thermo Fisher Scientific Latest Developments &nbsp;11.16 CBM &nbsp;11.16.1 CBM Company Information &nbsp;11.16.2 CBM Cell Therapy CDMO Product Offered &nbsp;11.16.3 CBM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 CBM Main Business Overview &nbsp;11.16.5 CBM Latest Developments &nbsp;11.17 Bio Elpida &nbsp;11.17.1 Bio Elpida Company Information &nbsp;11.17.2 Bio Elpida Cell Therapy CDMO Product Offered &nbsp;11.17.3 Bio Elpida Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 Bio Elpida Main Business Overview &nbsp;11.17.5 Bio Elpida Latest Developments &nbsp;11.18 Genezen &nbsp;11.18.1 Genezen Company Information &nbsp;11.18.2 Genezen Cell Therapy CDMO Product Offered &nbsp;11.18.3 Genezen Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.18.4 Genezen Main Business Overview &nbsp;11.18.5 Genezen Latest Developments &nbsp;11.19 CCRM &nbsp;11.19.1 CCRM Company Information &nbsp;11.19.2 CCRM Cell Therapy CDMO Product Offered &nbsp;11.19.3 CCRM Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.19.4 CCRM Main Business Overview &nbsp;11.19.5 CCRM Latest Developments &nbsp;11.20 RoslinCT &nbsp;11.20.1 RoslinCT Company Information &nbsp;11.20.2 RoslinCT Cell Therapy CDMO Product Offered &nbsp;11.20.3 RoslinCT Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.20.4 RoslinCT Main Business Overview &nbsp;11.20.5 RoslinCT Latest Developments &nbsp;11.21 GenScript ProBio &nbsp;11.21.1 GenScript ProBio Company Information &nbsp;11.21.2 GenScript ProBio Cell Therapy CDMO Product Offered &nbsp;11.21.3 GenScript ProBio Cell Therapy CDMO Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.21.4 GenScript ProBio Main Business Overview &nbsp;11.21.5 GenScript ProBio Latest Developments 12 Research Findings and Conclusion

Report	Global Cell Therapy CDMO Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI7043

Buyer Information

Order Summary